Tactile Systems Technology (TCMD) VP sells stock sale in 10b5-1 plan

Rhea-AI Filing Summary

Tactile Systems Technology’s Senior Vice President of Marketing & Clinical Affairs, Kristie Burns, reported a planned sale of company stock. On January 2, 2026, she sold 5,139 shares of common stock at a price of $28.85 per share under transaction code “S,” which indicates a sale. After this trade, she beneficially owned 72,401 shares of Tactile Systems Technology common stock in direct ownership.

The sale was made pursuant to a Rule 10b5-1(c) trading plan, which the disclosure notes was adopted on September 11, 2025. Such plans allow insiders to prearrange trades of company stock according to preset instructions, helping separate personal trading decisions from access to inside information.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burns Kristie

(Last) (First) (Middle)

3701 WAYZATA BLVD.

STE 300

(Street)

MINNEAPOLIS MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TACTILE SYSTEMS TECHNOLOGY INC [ TCMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. VP Mktg & Clinical Affairs

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		S(1)		5,139	D	$28.85	72,401	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Adoption date of referenced 10b5-1(c) plan is: 9/11/2025.

	/s/ Jonathan Zimmerman, Attorney-in-Fact	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did TCMD executive Kristie Burns report?

Kristie Burns, Senior Vice President of Marketing & Clinical Affairs at Tactile Systems Technology, reported selling 5,139 shares of common stock on January 2, 2026.

At what price did the TCMD shares sell in this Form 4 filing?

The reported sale of Tactile Systems Technology common stock was at a price of $28.85 per share.

How many TCMD shares does Kristie Burns hold after the reported sale?

Following the transaction, Kristie Burns beneficially owned 72,401 shares of Tactile Systems Technology common stock in direct ownership.

Was the TCMD insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing states that the transaction was made under a Rule 10b5-1(c) trading plan, with an adoption date of September 11, 2025.

What is the role of the reporting person at Tactile Systems Technology (TCMD)?

The reporting person, Kristie Burns, serves as Senior Vice President, Marketing & Clinical Affairs at Tactile Systems Technology.

Is this TCMD Form 4 filed by more than one reporting person?

No. The document indicates that the Form 4 was filed by one reporting person, Kristie Burns.